Ligand Pharmaceuticals Inc (NAS:LGND)
$ 81.36 -1.01 (-1.23%) Market Cap: 1.46 Bil Enterprise Value: 1.16 Bil PE Ratio: 15.29 PB Ratio: 1.81 GF Score: 76/100

Ligand Pharmaceuticals Inc Analyst Day Transcript

Mar 12, 2019 / 02:00PM GMT
Release Date Price: $70.68 (+2.14%)
Todd Pettingill
Ligand Pharmaceuticals Incorporated - Director of Corporate Development

Okay. Great. We've hit the top of the hour. So I just like to, real quick, welcome you to Ligand's 2019 Analyst Day. If you're in the room, I'd like to point you to investor.ligand.com, where you can get access to the slide deck.

So real quick, I'm Todd Pettingill. You probably heard my voice a little bit, speak to you on the phone. I'd like to welcome, we're excited to have you here.

And just very quickly, just wanted to do the standard safe harbor statement. Today, we're going to be making statements about our intents and beliefs. We -- this goes into the detail of -- in the detail of what we -- if you look in our SEC filings, you can see more detail of our -- of the specific breakdowns of our beliefs, but these are intentions -- beliefs and intentions in there as of today, March 12, 2019.

With that, I will turn the time over to John Higgins, our CEO.

John L. Higgins
Ligand Pharmaceuticals Incorporated - CEO & Executive Director

Todd,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot